Certificate record
Tesofensine, lot TECAP02
ILS Laboratories assayed lot TECAP02 of Tesofensine from Next Gen Peptides at 99.79% purity on 8 Jul 2026, reporting 0.52 mg against a 0.5 mg label, 4.0% above the labelled mass.
Assayed 8 Jul 2026 · ILS Laboratories · Next Gen Peptides · record id coa-www-tecap02
What the certificate reports
| Compound | Tesofensine |
|---|---|
| Lot identifier | TECAP02 |
| Purity | 99.79% |
| Labelled mass | 0.5 mg |
| Assayed mass | 0.52 mg |
| Difference | 4.0% above the label |
| Assay date | 8 Jul 2026 |
| Testing laboratory | ILS Laboratories |
| Who commissioned it | Published by the vendor. Scored as a claim, not as corroboration — only an independently commissioned assay counts as verified. |
| Source document | https://ngpeptide.com/wp-content/uploads/2026/06/nextgen-peptides-TECAP02-Ai-GbU.pdf |
Check it yourself
You do not have to trust this page, or the vendor. ILS Laboratories publishes its own lookup, so the report can be pulled from the laboratory directly.
Every ILS certificate carries a 7–8 character access code beneath the QR code in its header. Enter it on the laboratory’s verify page, or scan the code, and the report comes back from the laboratory’s own database.
Open the ILS Laboratories lookup and compare what it returns against the figures above. If the two disagree, the laboratory is right and we want to hear about it.
A certificate describes the sample it names and nothing else. It is not a statement about any other lot, and it is not an endorsement of the vendor or of any use of the material.
Other lots from Next Gen Peptides
- BPC-157, lot bpc10-10 99.73% · 23 Sept 2026
- PT-141, lot pt10-04 99.93% · 23 Sept 2026
- Epithalon, lot epth50-08 99.17% · 23 Sept 2026
- GHK-Cu, lot ghk-15 99.92% · 23 Sept 2026
- Selank, lot slk09 99.58% · 23 Sept 2026
- BPC-157, lot BC10-11 99.83% · 22 Sept 2026